Alzheimer’s disease (AD) is the most common neurodegenerative disease which is becoming increasingly prevalent due to ageing populations resulting in huge social, economic, and health costs to the com
From left: primary kinase target of the inhibitor, name of the inhibitor, reported in vitro IC50 values in literature, company from where the inhibitor was procured, mechanism of action with regard to
Investigation of proteostatic effects of HSP90 inhibition by 17-AAG and differentiation of maturation state dependent HSP90 requirements of proteins in resting T-cells.
